Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups

Journal of Infection（2022）

引用 72|浏览23

暂无评分

摘要

•COVID-19 vaccine antibody response and effectiveness was evaluated amongst clinical risk groups.•High effectiveness was observed and normal response maintained in most risk groups.•However, effectiveness was lower and antibody response reduced in the immunosuppressed group.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要